• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从爱泼斯坦-巴尔病毒感染的初始阶段到持续阶段,人类CD8(+) T细胞反应的表位特异性演变。

Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection.

作者信息

Hislop Andrew D, Annels Nicola E, Gudgeon Nancy H, Leese Alison M, Rickinson Alan B

机构信息

CRC Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom.

出版信息

J Exp Med. 2002 Apr 1;195(7):893-905. doi: 10.1084/jem.20011692.

DOI:10.1084/jem.20011692
PMID:11927633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2193726/
Abstract

Primary virus infection often elicits a large CD8(+) T cell response which subsequently contracts to a smaller memory T cell pool; the relationship between these two virus-specific populations is not well understood. Here we follow the human CD8(+) T cell response to Epstein-Barr virus (EBV) from its primary phase in infectious mononucleosis (IM) through to the persistent carrier state. Using HLA-A2.1 or B8 tetramers specific for four lytic cycle and three latent cycle epitopes, we find marked differences in the epitope-specific composition of the T cell populations between the two phases of infection. The primary response is dominated by lytic epitope specificities which are severely culled (and in one case extinguished) with resolution of the acute infection; in contrast latent epitope specificities are less abundant, if present at all, in acute IM but often then increase their percentage representation in the CD8 pool. Even comparing epitopes of the same type, the relative size of responses seen in primary infection does not necessarily correlate with that seen in the longer term. We also follow the evolution of phenotypic change in these populations and show that, from a uniform CD45RA(-)RO(+)CCR7(-) phenotype in IM, lytic epitope responses show greater reversion to a CD45RA(+)RO(-) phenotype whereas latent epitope responses remain CD45RA(-)RO(+) with a greater tendency to acquire CCR7. Interestingly these phenotypic distinctions reflect the source of the epitope as lytic or latent, and not the extent to which the response has been amplified in vivo.

摘要

原发性病毒感染通常会引发强烈的CD8(+) T细胞反应,随后该反应会收缩为较小的记忆T细胞库;这两种病毒特异性群体之间的关系尚未得到充分理解。在这里,我们追踪人类CD8(+) T细胞对爱泼斯坦-巴尔病毒(EBV)的反应,从传染性单核细胞增多症(IM)的急性期到持续携带状态。使用针对四个裂解周期和三个潜伏周期表位的HLA-A2.1或B8四聚体,我们发现在感染的两个阶段之间,T细胞群体的表位特异性组成存在显著差异。急性期反应主要由裂解表位特异性主导,随着急性感染的消退,这些特异性会被大量清除(在一种情况下完全消失);相比之下,潜伏表位特异性在急性IM中即使存在也较少见,但随后在CD8库中的百分比往往会增加。即使比较同一类型的表位,原发性感染中观察到的反应相对大小也不一定与长期观察到的反应相关。我们还追踪了这些群体中表型变化的演变,并表明,在IM中从统一的CD45RA(-)RO(+)CCR7(-)表型开始,裂解表位反应显示出更大程度地逆转为CD45RA(+)RO(-)表型,而潜伏表位反应则保持CD45RA(-)RO(+),且获得CCR7的倾向更大。有趣的是,这些表型差异反映了表位的来源是裂解性还是潜伏性,而不是反应在体内扩增的程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/2193726/e39b1e87c449/011692f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/2193726/773eb907ff16/011692f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/2193726/eb39ee20d34d/011692f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/2193726/ddffaba5e0f0/011692f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/2193726/9c6ae23a0e07/011692f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/2193726/e39b1e87c449/011692f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/2193726/773eb907ff16/011692f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/2193726/eb39ee20d34d/011692f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/2193726/ddffaba5e0f0/011692f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/2193726/9c6ae23a0e07/011692f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38e8/2193726/e39b1e87c449/011692f5.jpg

相似文献

1
Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection.从爱泼斯坦-巴尔病毒感染的初始阶段到持续阶段,人类CD8(+) T细胞反应的表位特异性演变。
J Exp Med. 2002 Apr 1;195(7):893-905. doi: 10.1084/jem.20011692.
2
Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.滑液中T细胞的特异性:对某些病毒表位具有特异性的CD8(+) T细胞的高频率存在。
Arthritis Res. 2000;2(2):154-64. doi: 10.1186/ar80. Epub 2000 Feb 7.
3
Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.EBV感染中表位特异性CD8(+) T细胞反应的差异进化与稳定性
J Immunol. 2001 Oct 15;167(8):4450-7. doi: 10.4049/jimmunol.167.8.4450.
4
EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function.EBV特异性CD8 + T细胞记忆:表位特异性、细胞表型与即刻效应功能之间的关系
J Immunol. 2001 Aug 15;167(4):2019-29. doi: 10.4049/jimmunol.167.4.2019.
5
Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory.针对爱泼斯坦-巴尔病毒的原发性细胞毒性T细胞反应中的表位聚焦及其与T细胞记忆的关系。
J Exp Med. 1996 Nov 1;184(5):1801-13. doi: 10.1084/jem.184.5.1801.
6
Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.类风湿关节炎患者外周血CD8 + CD28 - T细胞对EB病毒应答的扩增
J Rheumatol. 2005 Feb;32(2):239-51.
7
Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells.EBV表位特异性CD8+ T细胞的表型和功能异质性
J Immunol. 2002 Apr 15;168(8):4184-91. doi: 10.4049/jimmunol.168.8.4184.
8
MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.MHC II 四聚体可直观呈现人类 CD4+ T 细胞对 EBV 感染的反应,并显示核抗原 EBNA1 反应的非典型动力学。
J Exp Med. 2013 May 6;210(5):933-49. doi: 10.1084/jem.20121437. Epub 2013 Apr 8.
9
Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.健康病毒携带者中针对EB病毒裂解性和潜伏性抗原的CD8(+) T淋巴细胞频率
Virology. 1999 Nov 25;264(2):289-97. doi: 10.1006/viro.1999.9996.
10
Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential.重新表达CD45RA的爱泼斯坦-巴尔病毒特异性CD8(+) T细胞是具有抗凋亡能力且保留复制潜力的记忆细胞。
Blood. 2002 Aug 1;100(3):933-40. doi: 10.1182/blood-2002-01-0160.

引用本文的文献

1
Antigen specificity shapes distinct aging trajectories of memory CD8⁺ T cells.抗原特异性塑造记忆性CD8⁺ T细胞独特的衰老轨迹。
Nat Commun. 2025 Jul 10;16(1):6394. doi: 10.1038/s41467-025-61627-y.
2
Characterization of human CMV-specific CD8 T cells using multi-layer single-cell omics.利用多层单细胞组学对人巨细胞病毒特异性CD8 T细胞进行表征。
Cell Rep Methods. 2025 Jul 21;5(7):101085. doi: 10.1016/j.crmeth.2025.101085. Epub 2025 Jun 23.
3
Immune Monitoring after Cell Therapy and Hematopoietic Cell Transplantation: Guidelines by the ISCT Stem Cell Engineering Committee.

本文引用的文献

1
Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection.初次感染爱泼斯坦-巴尔病毒后抗原特异性CD8 + 细胞毒性T淋巴细胞的纵向动力学
Blood. 2001 Oct 15;98(8):2588-9. doi: 10.1182/blood.v98.8.2588.
2
Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.EBV感染中表位特异性CD8(+) T细胞反应的差异进化与稳定性
J Immunol. 2001 Oct 15;167(8):4450-7. doi: 10.4049/jimmunol.167.8.4450.
3
Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life.
细胞治疗和造血细胞移植后的免疫监测:国际细胞治疗协会干细胞工程委员会指南
Cytotherapy. 2025 May 5. doi: 10.1016/j.jcyt.2025.04.069.
4
The Functional Interaction Between Epstein-Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma.爱泼斯坦-巴尔病毒与MYC在伯基特淋巴瘤发病机制中的功能相互作用
Cancers (Basel). 2024 Dec 18;16(24):4212. doi: 10.3390/cancers16244212.
5
Evaluation of novel Epstein-Barr virus-derived antigen formulations for monitoring virus-specific T cells in pediatric patients with infectious mononucleosis.评价新型 Epstein-Barr 病毒衍生抗原制剂在监测传染性单核细胞增多症患儿病毒特异性 T 细胞中的作用。
Virol J. 2024 Jun 14;21(1):139. doi: 10.1186/s12985-024-02411-0.
6
Identification of HLA-A*11:01 and A*02:01-Restricted EBV Peptides Using HLA Peptidomics.利用 HLA 肽组学鉴定 HLA-A*11:01 和 A*02:01 限制性 EBV 肽
Viruses. 2024 Apr 25;16(5):669. doi: 10.3390/v16050669.
7
Overall avidity declines in TCR repertoires during latent CMV but not EBV infection.在潜伏的 CMV 感染期间,TCR 库的总体亲合力下降,但 EBV 感染不会。
Front Immunol. 2023 Nov 20;14:1293090. doi: 10.3389/fimmu.2023.1293090. eCollection 2023.
8
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice.淋巴节点靶向多表位亚单位疫苗促进 HLA 表达小鼠对 EBV 的有效免疫。
Nat Commun. 2023 Aug 8;14(1):4371. doi: 10.1038/s41467-023-39770-1.
9
Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous System.爱泼斯坦-巴尔病毒相关中枢神经系统疾病的治疗选择
Infect Drug Resist. 2023 Jul 13;16:4599-4620. doi: 10.2147/IDR.S375624. eCollection 2023.
10
T-cell dysfunction in natural killer/T-cell lymphoma.自然杀伤/T 细胞淋巴瘤中的 T 细胞功能障碍。
Oncoimmunology. 2023 May 24;12(1):2212532. doi: 10.1080/2162402X.2023.2212532. eCollection 2023.
ELISPOT法检测的γ干扰素分泌与A2/肽多聚体与T细胞受体(TCR)结合之间的差异揭示了细胞毒性T淋巴细胞(CTL)效应器功能与TCR-肽/主要组织相容性复合体(MHC)复合物半衰期之间的克隆间解离。
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10302-7. doi: 10.1073/pnas.181348898. Epub 2001 Aug 21.
4
Concurrent naive and memory CD8(+) T cell responses to an influenza A virus.对甲型流感病毒的同时幼稚型和记忆型CD8(+) T细胞反应
J Immunol. 2001 Sep 1;167(5):2753-8. doi: 10.4049/jimmunol.167.5.2753.
5
Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.霍奇金淋巴瘤患者血液及肿瘤部位的爱泼斯坦-巴尔病毒特异性细胞毒性T淋巴细胞反应:对基于T细胞的治疗的启示
Cancer Res. 2001 Aug 15;61(16):6219-26.
6
EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function.EBV特异性CD8 + T细胞记忆:表位特异性、细胞表型与即刻效应功能之间的关系
J Immunol. 2001 Aug 15;167(4):2019-29. doi: 10.4049/jimmunol.167.4.2019.
7
CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects.CD8(+)淋巴细胞在血清阴性和感染的受试者中对不同的HIV表位产生反应。
J Clin Invest. 2001 May;107(10):1303-10. doi: 10.1172/JCI12433.
8
Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection.急性和慢性HIV感染中HIV特异性细胞毒性T细胞特异性的显著差异。
J Exp Med. 2001 Jan 15;193(2):181-94. doi: 10.1084/jem.193.2.181.
9
Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.急性和早期HIV-1感染期接受治疗的个体的细胞免疫反应和病毒多样性
J Exp Med. 2001 Jan 15;193(2):169-80. doi: 10.1084/jem.193.2.169.
10
Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection.在对病毒感染的初次、记忆和再次应答过程中T细胞库的演变。
J Immunol. 2000 Dec 1;165(11):6081-90. doi: 10.4049/jimmunol.165.11.6081.